PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PTC Therapeutics Inc
Total Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Total Current Assets
$1.4B
CAGR 3-Years
8%
CAGR 5-Years
23%
CAGR 10-Years
19%
Abbvie Inc
NYSE:ABBV
Total Current Assets
$33.8B
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
7%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Assets
$12.3B
CAGR 3-Years
-4%
CAGR 5-Years
-18%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Total Current Assets
$27.2B
CAGR 3-Years
13%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Assets
$8.9B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
21%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Assets
$19.1B
CAGR 3-Years
13%
CAGR 5-Years
23%
CAGR 10-Years
26%

See Also

What is PTC Therapeutics Inc's Total Current Assets?
Total Current Assets
1.4B USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Total Current Assets amounts to 1.4B USD.

What is PTC Therapeutics Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
19%

Over the last year, the Total Current Assets growth was 130%. The average annual Total Current Assets growth rates for PTC Therapeutics Inc have been 8% over the past three years , 23% over the past five years , and 19% over the past ten years .

Back to Top